NFE2L2 and cystic fibrosis: Of note is that in CF an intrinsic downregulation of the antioxidant response regulator and NF-κB antagonist Nuclear Factor Erythroid 2-related factor 2 (Nrf2) is described (Moliteo et al., 2022).